German Federal Joint Committee (G-BA)
22
Mar 2022
On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.
Read more
09
Mar 2022
On February 16, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) has published the decisions which recommended the transfer to standard care for three completed projects. The projects relate to the prevention of antibiotic resistance, improvement of healthcare in socially disadvantaged areas, and misuse of control colonoscopies in Germany.
Read more
07
Feb 2022
On January 20, 2022, the Federal Joint Committee (G-BA) has initiated an evaluation procedure for early benefit assessment for the use of a stent retriever (pRELAX by femtos) to treat vasospasm of cerebral arteries after subarachnoid hemorrhage.
Read more
12
Jan 2022
On December 16, 2021, the Federal Joint Committee (G-BA) announced the start of the procedure concerning a co-funded study in accordance with §137e of the Social Code Book V (SGB V) for a low-intensity pulsed ultrasound for the treatment of pseudarthroses.
Read more
04
Jan 2022
On December 15, 2021, the Innovation Committee at the Federal Joint Committee (G-BA) has announced that seventeen applications for Innovation Funding of the new forms of care were accepted.
Read more
06
Dec 2021
On November 12, 2021, the Innovation Committee at the Federal Joint Committee (G-BA) has announced the selection of thirty project ideas for Innovation Funding of the new forms of care within the framework of the two-stage application process. A total of 123 project ideas were received, and only thirty were accepted.
Read more
26
Nov 2021
In early-mid November 2021, the Federal Joint Committee (G-BA) has initiated an evaluation procedure for early benefit assessment for two new cardiovascular technologies (Revivent TC™ by BioVentrix and Trilogy™ Heart Valve System by JenaValve Technology) in heart failure, and aortic valve insufficiency and stenosis, respectively.
Read more
14
Sep 2021
In late August 2021, the Innovation Committee at the Federal Joint Committee (G-BA) has announced funding of 52 innovative projects on health care research from the G-BA Innovation Fund.
Read more
24
Jun 2021
On June 7, 2021, the Innovation Committee at the Federal Joint Committee (G-BA) has reported that 123 project ideas were received for Innovation Funding of the new forms of care within the new two-stage application process framework.
Read more
26
May 2021
On May 6, 2021, the Federal Joint Committee (G-BA) announced the start of consultations about the design of three co-funded studies for cardiovascular methods in accordance with §137e SGB V.
Read more
19
May 2021
The Innovation Committee at the Federal Joint Committee (G-BA) has launched the decisions database on its website.
Read more
25
Mar 2021
On March 17, 2021, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities. Applicants are invited to submit ideas for projects that fall within one of these funding priorities. The deadline for submitting ideas is June 1, 2021.
Read more